Nanotechnology Databases

Comprehensive databases for nanomaterials, events, products,
companies, research labs, degree programs and publications

 

Nanobiotechnology and Nanomedicine Companies

 

Showing results 81 - 100 of 166 for companies in USA:

 
Keystone Nano has an exclusive license to Penn State patented technology that allows the creation of stable, non-toxic, 5 to 50 nm-composite particles that they call Molecular Dots (MDs). These Molecular Dots can encapsulate drugs and/or fluorescent molecules.
Develops and manufactures acoustic droplet ejection (ADE) systems, a fully automated, non-contact, nozzle-free technology to dispense nanoliters of liquids.
A cell culture/biotech company making strides in enhancing organ preservation and cell culturing at both room temperature and through cryopreservation. The LIFOR® technology is the nanoparticle component of the solution, which carries the oxygen or any type of drug or nutrient that the developers wish to place into the nanoparticle.
Develops and markets biological detection systems based on luminescent lanthanide complexes, which provide a unique combination of sensitivity, reliability, flexibility and high throughput.
Makefield Therapeutics has licensed Intellectual Property covering a novel platform technology from Albert Einstein College of Medicine of Yeshiva University for the generation of powders comprised of hydrogel/glassy matrix (hybrid) nanoparticles that in a first application are delivering controlled and sustained therapeutic levels of gaseous nitric oxide
The company is focused on realizing the potential of RNAi-based therapeutics through the development of a broad-based, state-of-the-art drug discovery platform built upon industry leading expertise in RNA chemistry and oligonucleotide delivery.
MSI's technology for multi-step multi-analyte chemiluminescent assays combines microfluidics, nanotechnology, and optoelectronics designed for both Immunoassay and Nucleic Acid Hybridization based applications.
The company utilizes its proprietary nanotechnology platform to transform existing and experimental anti-cancer agents into new, patentable drugs with superior pharmaceutical properties.
MicroConstants is a GLP-compliant Contract Research Organization (CRO) dedicated to providing premier quality bioanalytical, drug metabolism, pharmacokinetic, formulation and immunoassay support services to pharmaceutical and biotech companies worldwide.
Micronics, Inc. is a leading developer of near patient in vitro diagnostic products for disease diagnosis, prognosis and treatment monitoring. Capabilities include micro-nano assays.
The MicroTransponder, Inc. technology portfolio consists of a wireless micro-system that can interface with peripheral nerves and a host of biochemical micro/nano- sensors.
Develops nanoparticle based in vivo delivery applications.
Molecular Targets uses nanotechnology to develop diagnostic kits that will allow for the early detection of certain types of metabolic diseases.
NABsys is developing its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. This platform combines bleeding edge technology in physics, biochemistry, and computer science to sequence DNA in a way that is projected to be orders of magnitude cheaper and faster than any technology available today.
The company focused on delivering nanotechnology based innovative diagnostics products.
The company manufactures the Bio-Assembler, a device for culturing cells in three-dimensions by magnetic levitation. The Bio-Assembler combines nanoparticle based Nanoshuttle-PL with designed magnetic fields needed to levitate cells and provide the 3D cell growth environment.
A biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines, based on its nanotechnology platform.
Develops nanobiotechnology platforms that address global healthcare needs.
NanoBiotech is a broad-based life science company that discovers, develops, manufactures and markets a range of nanobiotics and medical diagnostics designed to improve people's health and longevity.
Nanocopoeia is a therapeutic particle engineering company providing nano-enabled particle design, services, and equipment to the pharmaceutical industry. Their patented ElectroNanospray™ (ENS) process is used to produce homogeneous nanoparticles in a unique one-step continuous process. They have the ability to engineer multicomponent particles. ENS is a non-destructive process operating at ambient temperature and pressure. The modular equipment design allows for easy entry at R&D scale moving to pilot and full scale production.
 
 
left arrowBack to Nanotechnology Links Directory